NFKB1 and neoplasm: Toll-like receptor (TLR), tumor necrosis factor receptor (TNFR), and interleukin (IL)-1 receptor initiate inflammatory signaling cascades in tumor cells in response to endogenous and exogenous carcinogenic stimuli, leading to nuclear factor-κB (NF-κB) activation.